ArticleJournal of clinical immunology2011

Endogenously activated interleukin-4 differentiates disease progressors and non-progressors in tuberculosis susceptible families: a 2-year biomarkers follow-up study.

Rabia Hussain et al.PubMed ↗Publisher ↗

No numbers read from the abstract.